Physiologically-based pharmacokinetic (PBPK) modeling and simulation has been regularly used to translate information from animals to humans to assist in dose selection and ‘First-in-Human’ studies. Certara’s animal PBPK platform, the Simcyp® Animal Simulators (SAS) include PBPK models for pre-clinical species such as the mouse, rat, dog, and monkey.
Since it is common to obtain drug specific in vitro and in vivo experimental data in pre-clinical species, the SAS can help us to understand the complex processes of ADME (absorption, distribution, metabolism, and excretion) and develop pharmacokinetic/pharmacodynamic (PK/PD) relationships that can be translated to humans.
Watch this webinar with Dr. Devendra Pade to learn more about the Simcyp Animal Simulators and the role they play in developing safer and more effective medications in the human and veterinary drug development arena.
The following enhancements and activities pertaining to the animal simulators will be discussed:
ADME Models in the Animal Simulators:
A summary of the enhancements done in the different mechanistic models such as the mechanistic oral absorption (ADAM) model, multi-compartment brain model and the availability of the different pharmacodynamic models will be discussed with examples.
The animal simulators are designed to adopt various strategies when evaluating data across different pre-clinical species or translation of various ADME processes to predict human PK. Some of these handy tools and strategies will be discussed.
By attending this webinar, you will leave with a greater appreciation of: